Experts urge registration of new child-friendly ARV formulation

Children living with HIV have to take multiple different antiretroviral pills or syrups twice a day, while most adults in South Africa have been offered one pill once a day regimens for around a decade. At the recent South African HIV Clinicians Society (SAHCS) conference, various speakers argued that better treatment regimens for kids are needed urgently. Thabo Molelekwa reports.

Read More

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.

Read More

HIV in Umkhanyakude: Impressive numbers, but living with HIV difficult amid socio-economic hardship

Premier of KwaZulu-Natal, Sihle Zikhalala praised the Umkhanyakude District recently on its ‘exceptional’ figures in meeting the UNAIDS 90-90-90 targets. Yet, when Spotlight recently visited the Jozini area, we were confronted with a less rosy picture. Some people stopped their HIV treatment because they do not have food to eat, and activists now warn that the progress with the targets can be derailed if poverty, hunger and other social determinants of health are not urgently and comprehensively addressed. Nomfundo Xolo reports.

Read More

From the frontlines: 20 years of fighting HIV in Khayelitsha

Two decades since Doctors without Borders (MSF) started its HIV programme in Khayelitsha, the organisation will start wrapping up its operations. Siyabonga Kamnqa spoke to some people living with HIV who benefitted from this programme and who now work as activists about developments over the last 20 years.

Read More

‘Welcome Back Service’ aims to help people get back on HIV treatment

While South Africa is doing well on some of the UNAIDS HIV targets for 2020, one target we are set to miss is ensuring that 90% of people diagnosed with HIV are on antiretroviral therapy. Partly in response to this problem, the ‘Welcome back’ campaign started by Doctors without Borders aims to make it easier for people who have stopped taking treatment to restart. Tiyese Jeranji reports.

Read More

U=U: We should put people living with HIV at the centre of HIV prevention efforts

The U=U campaign is based on a simple message – an undetectable viral load in people living with HIV equals an untransmissible virus. The U=U campaign, argues Mandisa Dukashe, has the power to motivate people living with HIV to adhere to ARVs, achieve viral suppression, and subsequently lead long and healthy lives while preventing HIV transmission to sexual partners and their babies.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More